Skip to content
Round-UpReport

CUE

Cue Biopharma, Inc.

1-for-30 reverse split, effective Apr 24, 2026.

Ratio
1-for-30
Effective date
Apr 24, 2026
Last day to buy
Apr 23, 2026

Prior NYSE session before the effective date. Calculated, not a filing field.

Be on record by
Filing does not state a record date
Fractional shares
Cash in lieu
Form
8-K

Filed Apr 22, 2026

Stockholders who would otherwise be entitled to a fractional share of Common Stock are instead entitled to receive a cash payment in lieu of such fractional shares.

From the filing, on fractional shares.

Read the SEC filing

Broker reports

No approved reports yet. If your broker handled this split, send a report.

New round-up filings and broker reports. Unsubscribe any time.